BBV Vietnam S.E.A. Acquisition Corp. Announces
Closing of Business Combination with Migami,
Inc. after Stockholders Approve All Proposals
April 21, 2010 05:07 PM Eastern Daylight Time
HANOI, Vietnam & WOODLAND HILLS, Calif.--(EON: Enhanced Online News)--BBV Vietnam S.E.A.
Acquisition Corp. (OTCBB: BBVVF)(OTCBB:BBVUF)(OTCBB:BBVWF) (the “Company” or “BBV”) and
Migami, Inc. (“Migami”) jointly announced they have completed their previously announced business combination.
The Company, which will be known as “Pharmanite Holdings, Inc.,” is the publicly traded holding company of
Pharmanite, Inc., its operating subsidiary. Pharmanite, Inc. will continue Migami’s business of developing,
commercializing and licensing drug delivery platforms and anti-aging cosmetics worldwide, with a special emphasis
John Park, the President and Chief Executive Officer of Migami and the new President and Chief Executive Officer
of the Company, stated, “This transaction represents an important milestone for Migami and provides us with the
platform to execute our growth strategy of developing, commercializing and licensing various drug delivery platforms
in Asia. We are excited about Migami’s opportunities for future growth, especially in oncology nano-delivery.”
At the Special Meeting of Stockholders held on April 14, 2010, the Company’s stockholders approved the
proposed business combination with Migami, Inc. as well as related proposals.
Pursuant to the Merger Agreement, the existing officers and directors of BBV resigned at the closing of the
transaction, and the senior management and board of directors of Migami remains unchanged and has been
appointed to assume the management of the Company. As a result of the transaction, Migami is now the majority
stockholder of the Company.
The Company intends to promptly file with the Securities and Exchange Commission a Current Report on Form 6-K
describing in more detail the transaction discussed in this press release.
Cautionary Note Regarding Forward Lo